RenovoRx appoints Angela Gill Nelms as COO; $400K salary, stock option grant

RenovoRx, Inc.

Angela Gill Nelms appointed COO effective Sept 19, 2022; previously COO at Florence Healthcare.
Annual base salary $400,000, discretionary bonus target 35%, option to purchase 274,230 shares.
Severance: 50% salary outside change-in-control, 100% plus full equity vesting during change-in-control period.
Company expects Phase 3 TIGeR-PaC interim analysis in Q4 2022; Nelms to oversee operations.
Also reimbursed up to $20,000 moving expenses.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Angela Gill Nelms

Chief Operating Officer

RNXT · RenovoRx, Inc.

Effective: 2022-09-19
Filed: September 19, 2022, 7:59 PM ET

The Board of Directors of RenovoRx, Inc. (the “Company”) has appointed Ms. Angela Gill Nelms, age 47, as Chief Operating Officer, effective September 19, 2022, her start date with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Angela Gill Nelms was appointed as Chief Operating Officer at RenovoRx, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

The Board of Directors of RenovoRx, Inc. (the “Company”) has appointed Ms. Angela Gill Nelms, age 47, as Chief Operating Officer, effective September 19, 2022, her start date with the Company.

View on SEC.gov

RenovoRx, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-026179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.